Parkinson's Disease Clinical Trials near Nashville, TN
15 studies for Parkinson's Disease are recruiting at 15 sites within 50 miles of Nashville, Tennessee, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Parkinson's Disease trials in the US or all trials near Nashville.
Recruiting now
Parkinson's Disease studies enrolling near Nashville
- Physiological Brain Atlas Development
NCT00575081
- Observational
- Ages 6 to 90 years
- Sex: All
Nearest site: Vanderbilt Univeristy (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
NCT01734122
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Natural History Study of Synucleinopathies
NCT01799915
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Vanderbilt Univeristy (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
NCT02897063
- Phase 1
- Ages 40 to 80 years
- Sex: All
Nearest site: Autonomic Dysfunction Center/ Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- [18F]F-DOPA Imaging in Patients With Autonomic Failure
NCT04246437
- Phase 1
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
NCT04715984
- Interventional
- Ages 40 years and older
- Sex: All
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Parkinson's Foundation PD GENEration Genetic Registry
NCT04994015
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Vanderbilt University (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Use of CereGate Therapy for Freezing of Gait in PD
NCT05292794
- Interventional
- Ages 21 to 80 years
- Sex: All
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
NCT05357612
- Phase 4
- Ages 50 to 85 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- CPAP for the Treatment of Supine Hypertension
NCT05489575
- Interventional
- Ages 40 to 80 years
- Sex: All
Nearest site: Autonomic Dysfunction Center/ Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830
- Phase 2
- Ages 40 to 80 years
- Sex: All
Nearest site: Vanderbilt University (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
NCT06944522
- Phase 3
- Ages 45 to 75 years
- Sex: All
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310
- Phase 3
- Ages 50 to 85 years
- Sex: All
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Neurophysiology of Reward Signaling in Parkinson's Disease
NCT07409207
- Interventional
- Ages 40 years and older
- Sex: All
Nearest site: Vanderbilt University Medical Center (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
NCT07432958
- Phase 2
- Ages 30 to 80 years
- Sex: All
Nearest site: Vanderbilt University Medical Center (Site #204) (Nashville, TN)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Parkinson's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.